Medsafe

A Medsafe committee says pholcodine-based dry cough syrups and lozenges, including some Difflam, Duro-Tuss and Pholcodine Linctus products, should be banned 

E-lockers that can be used as delivery portals for medicines and retail items are starting to be used atNew Zealand community pharmacies.

E-lockers are used extensively in European and US pharmacies, and are now being trialled in New Zealand 

Documents released under the Official Information Act show a single South Island pharmacy owner who had enough was the catalyst for the controversial unannounced audits programme being halted and put under review. Jonathan Chilton-Towle investigates

Documents released under the Official Information Act show a single South Island pharmacy owner who had enough was the catalyst for the controversial unannounced audits programme being halted and put under review. Jonathan Chilton-Towle investigates

Tim Hanlon has held top jobs in the UK’s NHS system and defence force and is now heading up a new directorate for the Ministry of Health. He talks to Paulette Crowley

Warning over men’s use of Epilim at time of conception issued by Medsafe 

Two pharmacies in Rotorua have closed after Medsafe suspended their operating licences 

Australia and Europe have banned medicines containing pholcodine. Now Medsafe is considering whether New Zealand should follow suit

Cough syrups and lozenges containing pholcodine have been recalled from pharmacy shelves in Australia and are under review in New Zealand